CNS Biomarkers: Drug Discovery, Research and Development

The term Biomarker can be characterized as a quantifiable marker of some organic state or condition. A biomarker can likewise be known as an organic biomarker. Meetings revolve around the advancement of CNS biomarkers for pharmaceuticals and diagnostics from Cerebrospinal fluid and Blood, and in addition imaging approaches. Logical information, updates and contextual analyses in neurological and neurodegenerative illnesses will be introduced on sickness regions, for example, Alzheimer's and Parkinson's.

  • Cerebrospinal fluid biomarkers
  • Neuroimaging enrichment biomarkers for CNS diseases
  • Biomarker Challenges in Rare Diseases
  • Technology case studies for CNS
  • CNS drug development using biomarkers

Advances in multimodality fusion imaging technologies promise to accelerate the understanding of the systems biology of disease and help in the development of new therapeutics. The use of molecular imaging biomarkers has been proven to shorten cycle times for central nervous system (CNS) drug development and thereby increase the efficiency and return on investment from research. Imaging biomarkers can be utilized to help choose the molecules, doses, and patients well on the way to test remedial speculations by ceasing those that have minimal possibility of achievement and accelerating those with potential to achieve beneficial clinical outcomes. CNS imaging biomarkers have the potential to drive new medical care practices for patients in the latent phases of progressive neurodegenerative disorders by enabling the detection, preventative treatment, and tracking of disease in a paradigm shift from today's approaches that have to see the overt symptoms of disease before treating it.

  • Clinical and Medical Case Reports
  • Innovations in Clinical Trials and Research
  • Early detection or screening trials
  • Patient safety and Outcomes
  • Healthy Brain Aging Study
  • CNS drug discovery and development
  • Methodological aspects
  • Fluid-based proteomic biomarkers
  • Functional biomarkers
  • Standardization of biomarkers
  • Automated analysis techniques
  • Standardized data collection and processing

Related Conference of CNS Biomarkers: Drug Discovery, Research and Development

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

CNS Biomarkers: Drug Discovery, Research and Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in